| 12161724 |
Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens |
David CAMPBELL, Thomas R. DIRAIMONDO |
2024-12-10 |
| 11111305 |
Method of using a bispecific antibody to conditionally inhibit a receptor signaling complex |
Todd Kinsella, Donald Payan, Kristen BALTGALVIS |
2021-09-07 |
| 11104737 |
ACVR2A-specific antibody and method of treatment of muscle atrophy |
Todd Kinsella, Kristen BALTGALVIS |
2021-08-31 |
| 10759855 |
Antigen binding molecules to TIGIT |
Todd Kinsella, Wei Li |
2020-09-01 |
| 10300140 |
Sur-binding proteins against ERBB3 |
Pamela K. Foreman, Lawrence Horowitz, Michael Horowitz, Medini Gore, Phil Kobel |
2019-05-28 |
| 10214580 |
Constructs and libraries comprising antibody surrogate light chain sequences |
Lawrence Horowitz, Li Xu |
2019-02-26 |
| 10216897 |
Construction of diverse synthetic peptide and polypeptide libraries |
Lawrence Horowitz, Aaron L. Kurtzman |
2019-02-26 |
| 10017561 |
Neutralizing molecules to influenza viruses |
Lawrence Horowitz, Arun K. Kashyap |
2018-07-10 |
| 9975956 |
Surrogate binding proteins which bind DR4 and/or DR5 |
Arun K. Kashyap, Michael Horowitz, Lawrence Horowitz, Sihong ZHOU, Ryann E. O'Neil +3 more |
2018-05-22 |
| 9169318 |
Neutralizing molecules to viral antigens |
Lawrence Horowitz, Arun K. Kashyap |
2015-10-27 |
| 8969082 |
Expression of surrogate light chains |
Lawrence Horowitz |
2015-03-03 |
| 8716195 |
Antibody ultrahumanization by predicted mature CDR blasting and cohort library generation and screening |
Guido Cappuccilli, Roberto Crea, Takeuchi Toshihilo, Randy Shen, Nurten Beyaz-Kavuncu |
2014-05-06 |
| 8148085 |
Donor specific antibody libraries |
Lawrence Horowitz, Arun K. Kashyap |
2012-04-03 |
| 8131480 |
Construction of diverse synthetic peptide and polypeptide libraries |
Lawrence Horowitz, Aaron L. Kurtzman |
2012-03-06 |
| 8114967 |
Constructs and libraries comprising antibody surrogate light chain sequences |
Lawrence Horowitz, Li Xu |
2012-02-14 |
| 5512435 |
Receptor-binding antiproliferative peptides |
Markus RENSCHLER, Ronald Levy, William J. Dower |
1996-04-30 |